Edwards Lifesciences Shareholders Equity Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 137.54  0.45  0.33%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Shareholders Equity of Edwards Lifesciences Corporation with missing and latest data points interpolated. A principal component of the balance sheet, in addition to Total Liabilities and Total Assets, that represents the total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.
Shareholders Equity  10 Years Trend  
Increasing
Slightly volatile
 Shareholders Equity 
      Timeline 

Regression Statistics

Arithmetic Mean  1,663,734,008
Geometric Mean  1,476,191,596
Coefficient Of Variation  46.44
Mean Deviation  663,026,472
Median  1,479,300,000
Standard Deviation  772,711,957
Range  2,237,142,105
R Value  0.98
R Squared  0.96
Significance  0.00000001
Slope  194,022,817

Edwards Lifesciences Shareholders Equity Over Time

2016-12-31  2,619,000,000 
2017-12-31  2,619,000,000 
2018-12-31  2,695,842,105 

Other Fundumenentals

My Equities

My Current Equities and Potential Positions
View AllNext
EW - USA Stock
Edwards Lifesciences Corporation
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
$137.54

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.